22% (6,785) of veterinary surgeons eligible to vote did so, compared to the previous record of 18.8%.
The votes were as follows:
For the two places available on VN Council one new member was elected and one existing member re-elected for four year terms. Andrea Jeffery was re-elected with 1,293 votes, while Susan Howarth was elected with 1,064 votes.
Eleanor Ferguson, RCVS Registrar, said: "Congratulations to all those elected to RCVS Council and VN Council and thank you to all those who stood as candidates in both elections.
"We would especially like to thank Jerry Davies, Peter Jinman and Bradley Viner who are standing down from RCVS Council this year after deciding not to seek re-election, in addition to Chris Gray and Tom Witte for their contributions to RCVS Council and Marie Rippingale for her contribution to VN Council.
"Thank you also to all those who took the time to ask questions of our candidates and cast a vote. This year we made a concerted attempt to make it even easier for the electorate to vote, with secure links to the voting websites sent by email and regular email reminders to those who hadn’t yet voted. The fact that both record numbers and proportions of the professions voted this year is testament to our efforts to further increase engagement with veterinary surgeons and veterinary nurses.
"However, while we welcome these significant increases, we recognise that it is still a relatively small proportion of the profession voting in these elections and so will continue to think of new ways to engage with the professions not just at election time, but across our many activities."
All the successful candidates will take up their positions at RCVS Day – the College’s Annual General Meeting and Awards Day – on Friday 7 July 2017 at the Royal Institute of British Architects where the formal declaration of both election results will also take place.
As part of the redevelopment, kennel capacity will increase from 107 to 197, there'll be a new emergency and critical care hub, sixteen new consult rooms and a new imaging suite with MRI and CT scanners, two ultrasounds and two X-ray machines.
There will also be a 66-seat seminar room.
Work is expected to be completed early next year, and the practice will be recruiting for around 75 new team members to service the expanded centre.
Simon Tappin, clinical director at DWR, said: “This long-awaited expansion will transform our practice, offering even more space and capacity for referrals, brand-new equipment and a seamless experience for our clients.
“It will also bolster our reputation as a training practice, with the expansion of our intern and residency programmes adding to our already-impressive provision in this area."
The practice is also implementing case management changes, with a single point of contact for every client and individual case managers in every discipline.
The traditional reception area is being replaced with a concierge greeting service for clients, with staff on hand to book them in on iPads.
Client care team manager Deborah Bell said: “This is a USP for us and we think it’s an industry first. The idea came from how medical secretaries work in human health.
“When a referring vet calls us, our client care team takes the basic details and passes them on to the case manager for that discipline. They will contact the client, make appointments and meet the client in person on arrival.
“We have 12 case managers for our disciplines at the moment, with the potential to expand. As well as providing a personalised service for our clients, it provides great career progression opportunities for our client care team.”
www.dickwhitereferrals.com
MDC Exports had launched a new biodegradable poo bag dispenser, aimed at veterinary practices and pet owners.
The idea is that pet owners can fix the dispenser to a wall, somewhere they'll be able to grab a bag on their way out of the door. The dispenser also has two strong hooks for other essentials such as dog leads or keys.
MDC Exports says their poo bags are generously-sized and feature long handles for simple tying and carrying. For more information, contact MDC Exports Limited on 01582 655600, or e-mail: mdcexports@btconnect.com
Oh I wish I was a travel journalist sometimes.
Zoë, who joined Davies in October 2020, was formerly a Senior Lecturer in Small Animal Surgery and Head of Soft Tissue Surgery at the RVC. She holds RCVS Certificates in Veterinary Diagnostic Imaging and Small Animal Surgery and is a Diplomate of the European College of Veterinary Surgeons.
Zoë is also a champion of sustainability: she completed the Cambridge Institute of Sustainable Leadership course and was appointed chair of the Vet Sustain working group to coordinate sustainability collaborations amongst veterinary professionals and societies. As a member of Vet Sustain’s curriculum working group Zoë is actively involved with supporting sustainability initiatives at UK veterinary schools and she continues to work with the RVC in a number of capacities.
She said: “I am honoured to have been awarded a fellowship and proud to join numerous outstanding colleagues who have already achieved this status.”
Tim Richardson, Managing Director of Davies said: “We are all extremely proud that Zoë’s outstanding knowledge, experience and contributions to clinical practice have been recognised at the highest level with the award of a Fellowship and we feel very privileged to have her here on the team at Davies.”
The RCVS Registered Veterinary Nurse Disciplinary Committee has suspended a Northants-based registered veterinary nurse who admitted to acting dishonestly with her employer, a client and a pet database company by taking home a patient that was supposed to have been euthanised.
During the two-day hearing, the Committee heard how Sally-Ann Roberts, formerly of the Best Friends Veterinary Group in Thrapston, had deliberately gone against the wishes of the owners of a 14-year-old Maine Coon cat called Jason that he be euthanised, rather than treated further, and instead had taken the cat home with her for "intensive nursing". Jason had subsequently escaped from Ms Robert's residence, leading her to fabricate a story, first to the pet database company, and then to Jason's owners and her employer, that he had escaped from the practice, before being returned by a member of the public two days later and then euthanised as originally requested.
Ms Roberts acted with her veterinary surgeon colleague Przemyslaw Bogdanowicz, who chose not to euthanise Jason and who, for his part, received a three-month suspension from the RCVS Disciplinary Committee in December 2012. She repeated the false account on a number of occasions, both orally and in written statements, and also forged the signature of Jason's owner on official documentation in order to substantiate her story.
Only when Ms Roberts was interviewed for a second time by her then employer's area manager, did she finally admit to what had actually happened. Shortly afterwards, Ms Roberts was suspended from the practice and, following an internal disciplinary hearing a few days later, was dismissed by them for gross misconduct, along with Mr Bogdanowicz. There was no evidence available as to what ultimately happened to Jason.
Explaining her actions to the Committee, Ms Roberts said she was upset that Jason's owners wanted him to be euthanised and felt that he could recover if given some love and attention. She had asked Mr Bogdanowicz to discuss this possibility with Jason's owners, but he had refused, agreeing instead that she could continue Jason's treatment at her home. After Jason escaped, Ms Roberts said she was "devastated" and had "panicked", inventing the story of Jason's escape to cover her actions, which she now acknowledged were "wrong" and "stupid", and which she "bitterly regretted". Ms Roberts expressed sorrow and remorse for her behaviour, which she said would never occur again, and stated that being a veterinary nurse was everything to her.
In view of the admitted facts, the Committee judged that Ms Robert's dishonesty and breach of client trust, as well the distinct risk of injury to which she exposed Jason, amounted to serious professional misconduct. In deciding on an appropriate sanction, the Committee balanced a number of aggravating factors (in particular, the forged signature) against Ms Roberts' "strong mitigation", which included her admitting the entirety of the charges against her, her medical and personal problems at the time, the insight she had shown into the effects of her actions on Jason's owners and her previous unblemished career.
Professor Peter Lees, chairing and speak on behalf of the Committee, said: "The Committee has concluded that the Respondent has shown insight into the seriousness of her misconduct and that there is no significant risk of repeat behaviour. In light of the Respondent's admission, her insight, her remorse and the high regard in which she is held by her professional colleagues, it is the Committee's view that the sanction of two months' suspension is appropriate and proportionate."
The Committee's full decisions on facts and sanction are available at www.rcvs.org.uk/disciplinary.
This year, 13 veterinary surgeons stood for three available places on Council.
6,583 veterinary surgeons voted, a turnout of 18.6% which was significantly down on previous years (24.5% in 2021, 26.2% in 2020 and 25.5% in 2019).
Sue Paterson led the field with 2,358 votes, Olivia Cook came in second with 1,994 votes and Abbie Calow was close behind with 1,820 votes.
Eleanor Ferguson, RCVS Registrar and Returning Officer for both elections, said: “Many congratulations to all successful candidates, who we look forward to welcoming on to RCVS and VN Councils in July.
"Thank you once again this year to everyone who made the decision to stand in this year’s elections and to those who took the time to vote for their preferred candidates.
"We’re not exactly sure why both elections saw falling turnouts this year, but we do appreciate how extremely busy the professions are at the moment, and that everyone’s time is at a premium.
"As part of our ‘Council culture’ project we are looking at ways of improving all aspects of communicating the work around RCVS Council, VN Council and their committees, including around standing for and voting in elections.”
The full results for the RCVS Council election can be found on the 2022 election page.
The RCVS Disciplinary Committee has suspended a Cardigan veterinary surgeon from the RCVS Register for five months, for failure to perform accurate bovine tuberculin testing and for falsely certifying the test results.
During the two-day hearing, Dewi Wyn Lewis, of Priory Veterinary Ltd, Cardigan, answered charges about inaccurate skin fold measurements and false certification relating to two visits he made as an Official Veterinarian to a farm in April 2009 to undertake tuberculin testing.
Mr Lewis accepted that he had not carried out the tuberculin tests in the way required by Animal Health (AH) - an Executive Agency of the Department for Environment, Food and Rural Affairs - and had taken short cuts to save time. However, he denied the charges, arguing that, although instructions to Official Veterinarians clearly required the use of callipers to measure the skin folds of cattle necks on Day One of testing, not using callipers and using his finger and thumb did not amount to failing to measure.
He also argued (and it was accepted by the Committee) that, regarding Day Two of testing, there was inconsistency in AH's instructions on calliper use, which in written form required using callipers for measuring every animal but in practice accepted use of callipers when a reaction could be detected by manually palpating the skin. On Day Two, Mr Lewis said, he had done what AH required: he had used callipers on the cattle he identified for closer examination.
The Committee, however, found that by failing to use callipers on the first day, as required by AH, Mr Lewis had failed to measure the skin folds of almost all of the 104 cattle. The Committee was also satisfied that, on the second day, 10-20% of the herd were not even touched by Mr Lewis and the Committee accepted the evidence of the three other witnesses present during the testing, which indicated that Mr Lewis had failed to carry out careful assessment and manual palpation of every animal.
The Committee then considered whether Mr Lewis had dishonestly signed the certificate, or had signed a false certificate which he ought to have known was inaccurate. The Committee noted that there were no previous Disciplinary findings against Mr Lewis, and was prepared to believe his assertion that, although he knew he had not carried out the tests in strict compliance with AH's instructions, he genuinely believed his methods to be at least as accurate as measuring with callipers and did not think he was doing anything wrong or dishonest. The Committee could not then be sure that Mr Lewis had realised what he was doing was dishonest. However, the Committee noted that 'false' also means 'inaccurate' and, as Mr Lewis ought to have known that as his testing methods were not adequate, he also should have known that a considerable number of measurements on the certificate were inaccurate and that the certificate itself was inaccurate.
After considering the facts of the case, the Committee concluded that Mr Lewis's actions amounted to serious professional misconduct and directed that he should be suspended from the Register for five months, after which he may return to practice. In relation to the sanction, the Committee said: "In reaching this decision it is relevant that the false certification was not dishonest and that there was professional and personal mitigation put forward on behalf of Mr Lewis. The Committee has paid regard to the fact that Mr Lewis is an experienced veterinary surgeon who is highly thought of in his local area. It does not believe that there is any likelihood that he will repeat his previous conduct."
The Committee also said it gave considerable weight to the fact that Mr Lewis had had to wait an additional three-month period for the hearing because of an earlier adjournment.
The Legislation Working Party was set up on the recommendation of the College’s Brexit Taskforce, which considered that in light of the United Kingdom leaving the European Union and the deficiencies in the existing legislation, now would be a good time to review the Veterinary Surgeons Act 1966.
The Working Party, which is expected to have its first meeting in May, will be chaired by RCVS Junior Vice-President Professor Stephen May and will include the British Veterinary Association’s President, Gudrun Ravetz, RCVS CEO Nick Stace, RCVS Registrar Eleanor Ferguson, Chair of VN Council Liz Cox, RCVS Treasurer and Junior Vice-President elect Amanda Boag, and RCVS Council members Kate Richards and lay member Richard Davis.
The Working Party’s remit will be to ensure that the College’s vision for the future of veterinary legislation is given proper consideration so that it can respond to future opportunities to support a new Act; to propose a list of principles on which new legislation should be based; and to make recommendations as to whether the new legislation should be a ‘Veterinary Services Act’ providing an umbrella for allied professionals and exploring compulsory practice inspection.
Professor Stephen May said: "The UK leaving the EU will necessitate some changes to the Veterinary Surgeons Act as it currently exists so this feels like an opportune moment to carry out a wholesale review of the legislative basis for regulation of the veterinary profession in the UK.
"Clearly using 50-year-old legislation has its limitations, and while we have been able to make use of legislative reform orders and changes to the Royal Charter to make significant changes to the College – for example, in terms of our disciplinary and governance arrangements – the fact is that this somewhat antiquated legislation is the basis for all we do.
"For example under the current Act veterinary nurses still lack statutory regulation and protection of title, there is no underpinning for our continuing professional development (CPD) requirements and specialist/ advanced practitioner status and the College lacks the power of entry or similar power needed for compulsory practice inspection.
"We hope that, by giving the legislation a fresh look, we can consider how it could better cover the veterinary industry as a whole and not just the rather narrow definition given in the original Act."
The Legislation Working Party is to meet at least four times and will report to RCVS Council in due course.
The petition follows the news that IVC is to launch its own telemedicine service, joining three others already in the game, at least one of which is pushing for a relaxation of the rules surrounding the prescription of POM-V medicines.
For clarity, veterinary surgeons are currently allowed to remote prescribe medicines for animals that meet the definition of 'under his care' (i.e. seen immediately before, or "recently enough or often enough for the veterinary surgeon to have personal knowledge of the condition of the animal or current health status of the herd or flock to make a diagnosis and prescribe").
In other words, there is nothing to stop bricks and mortar practices offering video consultations and prescribing medicines to those of their existing clients that they have seen recently enough.
What Shams and the BVU are petitioning against is the idea of allowing companies staffed by veterinary surgeons to prescribe veterinary medicines for animals that they have never seen in the flesh.
They argue that remote prescribing will:
First and foremost risk animal patient welfare and herd health
Create a two-tier system of care within the profession
Break down the practice-based vet-client relationship
Disrupt veterinary services due to complications related to out-of-hours emergency cover, transfer of patient and patient histories etc. of remotely treated patients
Cause clients to face increased costs by paying for telemedicine consultations and then requiring examination and treatment in practice
Negatively impact the financial condition of veterinary practices and professionals.
These all seem very possible consequences of allowing remote prescribing, indeed some have already come to pass in the world of human medicine following the launch of Babylon.
The counter argument is that remote prescription will improve access to veterinary care as people don’t have to flog down to the practice for a flea treatment and the cost of a consultation is reduced. There is surely truth in that.
The other point that is fundamental to this debate is the type of drug being prescribed remotely. With so many small animal parasiticides having already gone OTC, is it really necessary to talk to a veterinary surgeon before buying a POM-V flea treatment? Perhaps not.
However, that doesn’t necessarily present a case for remote prescribing such drugs; if they don’t need veterinary input, then you could equally argue they just need reclassifying.
So, should you sign this petition? Well, I think so, yes. Remote prescribing will come. It’s inevitable. But given the risks, surely the pragmatic starting point is to trial remote prescribing amongst existing clients of bricks and mortar practices, and only if that is successful to broaden it to non-clients of bricks and mortar practices.
If both those proved successful, and with technology advancing in the background, it might then be sensible to look at whether non bricks and mortar practices could remote prescribe. But that’s quite a big ‘might’.
Meantime, you can sign the petition here: https://www.change.org/p/royal-college-of-veterinary-surgeons-stop-authorising-prescription-of-pom-v-without-physical-examination-of-the-patient
You can discuss the petition with Shams here: https://www.vetsurgeon.org/nonclinical/f/6/t/28273.aspx
Faecal matter transplantation (FMT) has been used in people to treat Clostridium difficile infections and has also been trialled in conditions such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
The researchers believe that FMT offers a potential new option for the treatment of chronic diarrhoea in dogs and the study will investigate whether it contributes to a more rapid resolution of clinical signs. The study is being conducted in association with eight other private practices or universities around the country.
Julien Bazelle, a European Veterinary Specialist in Small Animal Internal Medicine at Davies said: "The goal is to recruit, over a short period of time, canine patients with chronic small intestinal diarrhoea, for a randomised trial in which the cohort receives or not FMT at the time of the initial investigations and prior to any other treatment.”
Dogs aged 6 months to 10 years with a history of chronic small intestinal diarrhoea (+/- other GI signs) are needed to participate in the study. Half of the dogs will receive FMT and the other half will be managed without. FMT will be performed in eligible patients during the sedation for their routine abdominal ultrasound. Transplanted faecal matter will be administered via a retention enema.
To be eligible, dogs must not have received antibiotics, probiotics or steroids recently.
If you have a potentially suitable patient please contact: julien.bazelle@vetspecialists.co.uk or Fergus.Allerton@willows.uk.net
The company points to a survey of 1000 dog owners it conducted in July which found that 77% would put many of the top ten signs of Cushing's down to ‘old age’.
According to research carried out by CM research in July 2018, for every 100 cases of Cushing’s syndrome treated, a further 57 are suspected but not diagnosed.
The ‘Prime Suspects’ campaign will encourage dog owners to become a ‘Cushing’s Detective’ and look out for signs in their dogs.
To help, the company has developed a series of characters to illustrate the signs of Cushings: Panting Patsy, Leaky Larry, Lazy Lynn, Greedy Gus and Little Patch.
A nationwide pet-focused multimedia campaign will support the ‘Prime Suspects’ initiative and will include TV and print advertising, online banners, pay per click advertising and social media to engage owners and encourage them to seek advice from their vet if they suspect Cushing’s in their dog.
Dechra has also launched Cushing’s Connect, a digital platform single resource hub to help vets keep up to date with current best practice in managing Cushing’s.
The hub has information and tools to enhance diagnostic protocols, advice and literature covering pathophysiology, diagnosis and ongoing case management including treatment protocols and monitoring schedules, and interactive guides and videos by top veterinary specialists.
There's also a client communication toolkit with owner-focused resources to encourage dog owners to spot the signs and seek help from their vet.
https://www.dechra.co.uk/cushings-connect
Luis Sainz-Pardo, a Spanish vet who migrated to the UK, has started VetAbroad, a new company which will offer advice and support to practices employing foreign vets, and training to non-UK practitioners in order that they are better equipped to work in this country.
Luis says it's not unusual for practice owners and managers to have concerns about how best to mentor and support non-UK veterinary graduates. Teamwork and a sense of what it means to be part of the UK veterinary community are essential. But cultural differences, professional obligations and coping with regional accents and idioms, all present significant challenges for both the non-UK vet and the practice employing them. Luis says he's experienced these challenges from both sides of the fence: first as a vet migrating to the UK and later as the owner of one of the first practices to achieve BSAVA practice standards.
To help foreign vets coming to the UK, VetAbroad has launched a new e-learning course Working as a foreign vet in the UK that trains non-UK vets to practise in the UK. It is suitable for graduates who've recently started to work here, those preparing for work in the UK and graduates who have been in the UK for longer but would benefit from brushing up on the expectations of UK regulatory bodies, clients and practices.
The 140-hour course includes a significant audio element to ensure competence in the understanding of spoken English. It addresses all aspects of life as a vet in the UK, including culture, necessary adaptations, the RCVS Code of Conduct, teamwork & productivity and client & patient care. The course ensures that graduates know what they need to fulfil their obligations of professional conduct, to respond appropriately to UK clients and to fit with the needs of busy UK veterinary practices.
To help practice owners and managers that employ foreign vets, VetAbroad offers a mentor scheme to help deal with their issues or concerns. For a nominal monthly fee, the mentor is able to counsel, provide advice, identify training needs, or liaise between the two parties, taking into account cultural differences, common misconceptions and barriers to communication. VetAbroad says the percentage of vets not adapting to the UK system is close to 50% and providing appropriate support is likely to improve employee retention, client satisfaction and productivity.
For more information, visit www.vetabroad.com
Metaxol contains 20 mg trimethoprim and 100 mg sulfamethoxazole per ml and can be added directly to drinking water or used in a concentrated stock.
The new product, which is part of the company's SoluStab range, replaces Methoxasol. Dechra says it is likely to be welcomed by farmers wanting to target entire flocks because of its shorter withdrawal time for broilers.
Dechra Brand Manager Emma Jennings said: "Sulfamethoxazole is a potent sulfonamide and, when combined with trimethoprim, it has a synergistic and bactericidal effect.
"Both active ingredients are rapidly absorbed and distributed widely in tissues making it a highly effective treatment.
"The shorter withdrawal time for broilers will make it an attractive treatment for farmers wanting to target entire flocks."
Metaxol is not suitable for laying hens.
In fattening pigs, Metaxol is suitable for the treatment and metaphylaxis of post-weaning diarrhoea caused by beta-haemolytic K88-positive, K99-positive or 987P Escherichia coli strains susceptible to trimethoprim-sulfamethoxazole.
It can also be used for secondary bacterial infections caused by Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus spp. and Haemophilus parasuis susceptible to trimethoprim-sulfamethoxazole.
In broilers, it can be used for treatment and metaphylaxis of Colibacillosis caused by Escherichia coli susceptible to trimethoprim-sulfamethoxazole or Coryza caused by Avibacterium paraga.
The recommended dosage is 0.25 ml of product per kg body weight per day for four to seven days for pigs and 0.38 ml of product per kg body weight per day for three days for chickens.
For support in calculating dosages, visit http://calculator.solustab.eu/.
A new injectable antibiotic with nil-milk-withhold licensed to treat foul-in-the-foot in a single shot has been launched by Pfizer Animal Health.
Naxcel Cattle's active ingredient is ceftiofur in a patented sustained-release formulation. According to the company, one injection provides a full course of antibiotic therapy, giving seven days of therapeutic blood levels against the majority of inter-digital necrobacillosis ('foul-in-the-foot') pathogens.
Pfizer vet Dave Gilbert says the expectation is that Naxcel Cattle will make on-farm therapy easier and help improve treatment compliance and thereby first treatment success rates, compared to treatments which require repeat injections. "Having the full course in a single injection simplifies treatment protocols and eliminates a number of reasons for non-completion of treatment, such as forgetting a second or third dose, or not giving them because of apparent symptomatic recovery from the condition."
The site of injection for Naxcel Cattle is the subcutaneous area at the base of the ear (see Figures 1 & 2). Injection instructions are supplied in the product pack. Dave Gilbert suggests that provided cattle are adequately restrained during administration the injection technique is simple and straightforward. The dose rate is 1ml/30kg body weight and up to 30ml can safely be given into each site.
Figure 1. Subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).Figure 2. Injection location for the subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).
The RCVS has announced that the Codes of Professional Conduct for veterinary surgeons and veterinary nurses have been updated to state that you should not refer to yourselves or others as 'veterinary nurses' unless registered.
In fact, the change occurred back in June last year, but was only announced via RCVS News and as a one-liner within the 'Overview of decisions made at RCVS Council'.
The announcement raises the pretty fundamental question of what ARE veterinary surgeons and RVNs to call their unqualified colleagues, if not veterinary nurses? How indeed are those unqualified staff working in veterinary practice to describe their job title to their friends, down at the pub?
VetSurgeon.org sought to clarify the situation with the College, and the first point to make is that the new part of the CoPCs refers only to the use of the words 'veterinary nurse' when used in conjunction. The words 'nurse' or 'nursing' are not protected at all.
The College says that it is not within its remit to instruct veterinary surgeons or registered nurses as to how they should address unqualified staff, but suggested: 'Care Assistant' or 'Auxilliary'.
However, Ben Myring, RCVS Senior Policy and Public Affairs Officer said: "There is nothing to stop someone calling themselves a 'nursing assistant' or a 'head nurse'".
The Codes of Professional Conduct obviously apply only to those who are regulated by it. The title 'veterinary nurse' in unprotected in law and can therefore be used by anyone else.
So, the immediate implications seem to be as follows:
Do you have any other suggestions as to how unqualified nursing staff should be styled? Post them below.
Given the improbability of anyone being alerted by a goldfish: "blub-blub-behind-blub-you-blub-blub-the-blub-frying-blub-blub-pan-is-blub-on-fire-blub", one has to presume the respondents were talking about dogs.
But no, according to npower, 10% of the participants in its survey reported that their cat or dog had directly saved their life, or the life of someone they know.
Really? Saved by a cat? I should have thought a cat would be more likely to turn on it's heels and strut out of the room nonchalantly.
Still, the point of the npower's research was to highlight the dangers of carbon monoxide. In its press release, the company pointed out that pets can suffer CO poisoning symptoms of vomiting, tiredness and erratic behaviour before people.
So perhaps that's what the cat owners meant when they'd been saved by the cat: like a miner would say they were saved by a canary.
The company says the aim is to identify the most effective ways to minimise the risks this common and debilitating infectious equine virus poses. The survey can be found here.
Equine Herpes Virus is a contagious virus, which can cause respiratory disease, abortion and more rarely neurological disease. In addition, sub-clinical infections can be associated with a syndrome of poor performance and have a potential effect on the health of the whole yard.1
The disease is transmitted from horse to horse through the respiratory tract, by inhalation of the viral particles shed by infected horses. Once a horse is infected with Equine Herpes Virus it is likely to be latently infected for life. Viral reactivation and nasal shedding can occur at any time, particularly during stressful periods such as when mixing with other horses at equine events. This can lead to acute disease episodes. Often affected horses are asymptomatic but if they do show symptoms these may include depression, lethargy, pyrexia, nasal discharge and a dry cough. Reduction of shedding through management and vaccination is key to disease control.2
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "EHV has potentially serious health, performance and financial implications across every sector of the equestrian industry.
"The aim of our survey is to find out more about current vet protocols in practice. The results should help us to identify and then ensure that the most effective prevention strategies are accessible to vets and their clients."
The survey runs from 4 – 22nd March 2019 in parallel to a separate survey for horse owners.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
References
The Disciplinary Committee of the Royal College of Veterinary Surgeons has directed that the name of a veterinary surgeon who had been practising in Essex be removed from the RCVS Register, having found him guilty of attempting to obtain medicines dishonestly.
James Alexander Lockyear, a graduate from Pretoria University in South Africa, was charged with two offences. The case was heard in his absence, although the Committee did not draw any adverse inference from this. One charge concerned his attempted purchase of steroids from a pharmacy in Colchester by dishonestly representing that the medicine was for legitimate veterinary use. The second charge related to several instances of what the Committee referred to as "inappropriate and unprofessional behaviour", including showing an offensive image to another staff member on a mobile phone, placing the testicle of a castrated dog in his mouth and the misuse of an endotracheal tube.
All of the incidents had taken place between April 2008 and September 2009, while Mr Lockyear was practising as a locum veterinary surgeon at St Runwald's Veterinary Surgery, Colchester, Essex.
The Disciplinary Committee heard evidence from a pharmacist, Mr Noble, to whom Mr Lockyear had presented an incomplete veterinary prescription for 12 ampoules of Sustanon, a prescription-only anabolic steroid for humans, and a further pharmacist, Mr Foskett MRPharmS, who outlined his suspicions that the steroids were in fact for Mr Lockyear's personal use (Sustanon is a substance which can potentially be misused in relation to body-building). Mr Lockyear had originally claimed the drugs were for general stock at the practice; he later returned with a second prescription, for double the amount of Sustanon, claiming it was for his own dog; later again, he said the prescription was for a friend's dog.
The Committee also heard evidence from the veterinary owner of the practice, a veterinary nurse and a student veterinary nurse working in the practice team, and from Dr Maddison MRCVS, an expert on small animal clinical pharmacology. Dr Maddison informed the Committee that there was a veterinary alternative to Sustanon, so it was not necessary for that drug to have been sought by Mr Lockyear. She was also of the view that Sustanon would not have been suitable to treat the ailments for which Mr Lockyear claimed it was to be used.
The Committee found Mr Lockyear guilty of the first charge - that is attempting to obtain medicines dishonestly. Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "Whilst it was a one-off incident, it is conduct which falls far short of that which is expected of a member of the profession. It involves serious dishonesty; it represents an abuse of a veterinary surgeon's authority to prescribe drugs; it is conduct which tends to undermine public trust in the profession, and the honesty of its members; it is conduct which compromised other professionals, the pharmacists involved, and undermined the trust which ought to exist between pharmacists and veterinary surgeons generally, in the important area of drug prescription." The Committee therefore directed that Mr Lockyear's name be removed from the Register.
Regarding the second charge, the Committee was most concerned about the incident relating to the dog's testicles, which it felt offended against Mr Lockyear's duty to treat with respect all animals which were his patients. Taking the three incidents as a whole, the Committee felt that Mr Lockyear should be seriously criticised for behaviour that was "unprofessional... juvenile, inappropriate, disgusting and offensive". However, they felt that the conduct was not malicious, and did not occur in the presence of a member of the public, so concluded that this did not amount to disgraceful conduct in a professional respect.
Published by CABI and sponsored by Mars Petcare UK, Companion Animal Economics was developed by Daniel Mills, Professor of Veterinary Behavioural Medicine at the University of Lincoln, and Dr Sandra McCune, Human-Animal Interaction expert at Mars Petcare’s WALTHAM Centre for Pet Nutrition. It documents and examines available evidence on the direct and indirect benefits and costs of companion animals to society, including their influence on human mental and physical health, illness prevention and well-being.
Other authors include Dr Sophie Hall from the University of Lincoln’s School of Life Sciences, Professor Ted Fuller and Luke Dolling from the Lincoln International Business School, and Katie Bristow-Wade of Dogs for Good.
Professor Mills said: "Vets are well aware how important companion animals are to their owners, but it is important that they appreciate the positive impact that they can have on the physical, mental and social health of both individuals and society more widely. This book should help raise awareness of this and their economic importance in times of economic uncertainty."
Dr McCune said: "Almost half of households in the UK share their homes with animals cared for as companions – a relationship we consider to be valuable and enriching. At Mars Petcare, we’re committed to creating A BETTER WORLD FOR PETS™. That’s because we know that pets make our world better. This important report provides a modern day update on the impact of companion animals on the UK economy and society, without reducing the discussion to a simplistic cost-benefits ratio. Critically, it aims to raise awareness of the need for research to evaluate the complex routes by which pets make an economic impact on UK society."
The author says relatively little information on the economic impact of pets has been published since the 1988 seminal Council for Science and Society (CSS) report on Companion Animals in Society, which inspired Companion Animal Economics. Since then, trends in pet ownership and associated industries, have changed a great deal. The report’s methodology sought to capture this new context, including issues like pet tourism, pet obesity, and expanding veterinary services, identifying clear gaps where further high-quality data and additional research are needed.
When evaluating the contribution of companion animals to the UK economy, both positive and negative aspects were considered. The cost of NHS treatment for bites and strikes from dogs is estimated at £3 million per year. At the same time, the report also estimates that pet ownership in the UK may reduce use of the UK health service by up to £2.45 billion per year. This conservative conclusion is drawn through examining healthcare savings through reduced number of doctor visits.
Given the scale of the potential impact, the report concludes that research into companion animals and their economic impact on society needs further investigation and should be supported by government. While UK data were used in the report, many of the points raised relate to other industrialised nations, demonstrating the global nature of this issue.
The new machine is a modular system using low-flow anaesthesia for animals from 2-80kg.
The company says that compared to anaesthetic techniques which use high fresh gas flow rates, it functions without posing a risk to team members from the huge amounts of oxygen and inhalational anaesthetic agents that would otherwise be released.
In turn, this results in cost savings from unwasted agents, and a typical 5 to 10 times reduction in environmental damage.
Darvall founder, Dr Colin Dunlop, said: “For optimal outcome from anaesthesia, veterinary anaesthesiologists and veterinarians routinely make decisions about the physiological well-being of the patient, the environmental impact of their actions, the operational efficiency of their practice and cost-effectiveness.
"Having suitable equipment that uses low-flow anaesthesia will reduce the risk of hypothermia, improve team safety, reduce environmental emissions and reduce costs.”
“Low-flow anaesthesia not only reduces oxygen flows and inhalant agent consumption to less than 10% of high-flow, non-rebreathing systems, it can help reduce anaesthetic hypothermia because it uses warm gas when using the Darvall heated breathing circuits.
"Using our specifically designed modern system for veterinary patients addresses the traditional challenges associated with low-flow anaesthesia and hypothermia.
Darvall says the use of just one system will also simplify staff training and ensure familiarity.
https://darvallvet.com
Intervet/Schering-Plough Animal Health has launched a new cattle and sheep vaccine which it says gives vets an additional opportunity to prescribe the broadest possible protection against clostridial diseases.
Bravoxin 10 is a low dose clostridial vaccine containing antigens for protection against C. perfringens type A, C.perfringens type B, C.perfringens type C, C.perfringens type D, C.novyi type B, C.septicum, C.tetani, C.sordellii, C.haemolyticum and C.chauvoei.
Dosage volumes are 2ml for cattle and 1ml for sheep and the new vaccine can be used in animals from as young as two weeks old if the dam has not been previously vaccinated. A booster dose pre-calving or lambing will also deliver 8-12 weeks passive immunity in calves and lambs (apart from against C.haemolyticum).
Intervet/Schering-Plough Animal Health ruminant veterinary adviser Rosemary Booth MRCVS said: "Clostridial bacteria take the lives of cattle and sheep on a regular basis and are the cause of a significant proportion of the sudden livestock deaths in this country. In 2007, an independent survey of over 500 UK dairy and beef farmers revealed that half the interviewees had experienced calves or adult cattle dying for no apparent reason. The reality is that many of these losses could have been due to clostridial diseases. Farmer respondents valued the livestock loss at anywhere between £505 and £1243 per animal. Even at the lowest stock valuation, preventing the loss through broad-spectrum vaccination would pay for nearly five years of Bravoxin 10 use in a 100 cow herd.
"Now that additional clostridial pathogens such as C. sordellii and C. perfringens A have been recognised by the VLA and SAC as significant causes of deaths on both cattle and sheep farms, it makes sense to widen pathogen cover on some ruminant livestock units. Bravoxin 10 allows practitioners to prescribe the broadest possible disease protection."
The sheep industry already understands the importance of broad-spectrum vaccination against clostridial diseases, but Iain Carrington from Intake Veterinary Services based in Northumberland believes cattle producers should also upgrade their protection.
"There was a time that clostridial disease control in cattle meant vaccinating your youngstock against blackleg at turnout, or discovering dead animals and then reacting with blackleg vaccine," he said. "But over the last few years, I have seen an increased incidence of different clostridial diseases in far from typical circumstances.
"There are also a large number of cattle deaths going undiagnosed and it is likely that many are caused by clostridial species. As a result, we are now advising many of our clients to take a broader-spectrum vaccination approach to ensure adequate protection - not only of the cows themselves - but also their calves through good colostral transfer," he said.
Bravoxin 10 is a prescription-only medicine (POM-V). For further information, contact the Intervet/Schering-Plough Animal Health Veterinary Support Group on 01908 685685.
The 12-month surgical guarantee covers professional fees, including consultations, anaesthesia and surgery, involved in rectifying a complication as long as the patient is in good health and the post-surgery instructions have been followed appropriately.
Clinical Director, Andy Moores, an RCVS-Recognised Specialist in Small Animal Orthopaedics, said: “We can never promise that surgery will be free of complications, but we are confident in our low complication rate.
"We are offering a surgical guarantee to demonstrate this confidence and to provide our clients with the reassurance that we will help them get through any post-surgical complications.”
Andy added: “Along with our highly competitive fixed-price fees we hope this guarantee will give owners financial peace-of-mind when their pet needs orthopaedic treatment at this difficult time.
"We do not know of any other specialist orthopaedic centre in the southeast that offers better value care.”
www.mooresortho.com
For free case advice, email: advice@mooresortho.com
Organisers of The London Vet Show 2009 report that the event was a great sucess, greeted with 'considerable delight' by delegates and exhibitors alike.
The event, which featured clinical and commercial lectures as well as a major exhibition, ran on 6th and 7th November at London's Olympia Conference Centre. 2410 veterinary professionals attended, and most were there for both days.
VetSurgeon.org attended the event, asking commercial exhibitors: "What's New?" Those of you that didn't make it to the show can click here to watch a video of their answers.
Overall feedback from vets about the quality of the CPD programme was overwhelmingly positive. Delegate feedback forms rated the quality of speakers in the programme as 4.39 out of 5, and rated the event as 4.68 out of 5 in terms of value for money.
Rachel Bolus of Riverside Veterinary Practice said: "All the lectures were to a really good standard - a lot of CPD for a very cheap price."
Bridget O'Farrell of Dick Vet Small Animal Practice agreed: "Very cheap for two days of CPD and the quality of the speakers has been very good. I went to five lectures yesterday and planning on six today. It's been a very worthwhile exercise and I would certainly recommend this to my peers".
Event organiser Phil Nelson said: "We have witnessed an amazing two days, surpassing all delegate estimates and it's gone down really well. The 2010 exhibition is already 40% bigger than this year almost 12 months out and looks set to sell out. We are carefully listening to the delegates and exhibitors comments, and have already a number of plans to develop and build the event going forward. But as a starting point we could never have dreamt for the launch event to be so well received."
For 2010 the London Vet Show is moving to the bigger Olympia National Hall having out grown the Conference Centre. It will run on October 22nd and 23rd. It is committed to retaining the same approach to offering affordable and World Class CPD qualifying clinical and commercial content for all the UKs vets. Having very quickly established itself as a major part of the veterinary calendar the organisers expect to announce their 2010 programme in the early part of 2010.
532 veterinary practices responded to the survey, which was sent to 3,096 veterinary practices for which the RCVS had a unique email address, on 3rd April.
The survey found that:
Three-quarters of those who responded to the survey answered a question on how the RCVS could better support veterinary practices through the crisis. The most frequent response (27%) was that the RCVS needed to provide clearer guidance, in particular as to what services it was permissible for veterinary practices to provide [the College published its updated guidance and flowchart on 9 April].
Of those who responded to the question, 15% felt that the RCVS was doing a good job or that there was nothing more it should do, while just 2% of responses expressed negative sentiment towards the RCVS.
Lizzie Lockett, RCVS Chief Executive, said: “I would like to thank all those practices who took the time in what is already a very fraught situation to respond to our survey and provide the evidence we need to gain a holistic picture of coronavirus’ impact on the business and economics of veterinary practices. We plan to continue running these surveys on a regular basis in order to gauge impact over time and the findings will feed into our policy and decision-making.
"This ongoing research will also be a vital tool when we are talking to Government and other bodies about the impact of policy on the veterinary sector. On this note, we are aware of the challenges of a minimum furlough period of three weeks given the need for practices to take steps to offer 24/7 emergency and critical care, and have written to government on this with some case studies around the impact this is having.
"To those on the ground it won’t come as too much of a surprise that the impact of the coronavirus has been profound in areas such as practice turnover and staffing, with many vets, veterinary nurses and other support staff being furloughed with the aim of signing them up to the Government’s Coronavirus Job Retention Scheme.
"There are some bright spots in the data we’ve gathered – very few practices reported that they had made or were planning to make staff redundant, and many practices reported mitigating the challenge of social distancing by carrying out consultations with new and existing clients remotely.
"Since the survey took place we have also taken steps to meet some of the requests for greater clarity and guidance from the RCVS with the publication of our flowchart helping practices to decide what treatments it is appropriate to carry out safely amidst the COVID-19 pandemic."
The survey results can be read in full at www.rcvs.org.uk/publications.
The next practice impact survey is planned for early May.
Norbrook Laboratories Ltd has launched Mycinor tablets (clindamycin), an antibiotic for treating soft tissue infections in dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Clindamycin is one of the leading prescription medicines used to treat soft tissue infections and offers very effective treatment particularly for dental and oral infections.
"Mycinor can be used to treat infected mouth cavities and oral infections and to provide antimicrobial cover prior to dental procedures such as tooth removal, scale & polish etc. Beyond dental expertise, Mycinor can also be used to treat soft tissue infections, skin infections in the form of superficial pyoderma and osteomyelitis bone infections. Mycinor is a fast acting antibiotic, rapidly absorbed into the body with effective levels within 30 minutes of administration."
Mycinor is available as 25mg, 75mg and 150mg in packs of 100tablets, and as a 300mg tablet in a pack of 150 tablets. Rebekah added: "Mycinor is a very effective and safe antibiotic and is ideal for long and short term treatments. It can be dosed once daily or at twice daily intervals if preferred."
For more information, visit www.norbrook.com